ALB three-lens brief
Evidence-based stock research on ALB. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Underperforming SPY by 28.9pp over 30 days. · Trading >3% below the 50-day MA — short-term weakness.
- Trading >3% below the 50-day MA — short-term weakness.
- RSI at 28 — technically oversold.
- Underperforming SPY by 28.9pp over 30 days.
- Analyst mean target $204.46 — 61% above current (20 analysts).
- Earnings scheduled 2026-07-29.
ALB closed at $126.89 (-1.20%) as of 2026-07-10. Market cap: $14.96B. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $204.46 — 61% above current (20 analysts).. Concerns: trading >3% below the 50-day MA — short-term weakness.; rSI at 28 — technically oversold.. Last quarter: Revenue $1.43B, net income $277.40M, free cash flow $716.71M. Watching for: 2026-07-29 earnings release (18 days out).
Why three lenses on ALB, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ALBacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ALB" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ALB brief"></iframe>